Literature DB >> 17657223

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.

R M de Tute, A S Jack, J A Child, G J Morgan, R G Owen, A C Rawstron.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17657223     DOI： 10.1038/sj.leu.2404815

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  Assessing minimal residual disease in chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Peter Hillmen
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

2.  Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma.

Authors:  Chiara Lobetti-Bodoni; Barbara Mantoan; Luigia Monitillo; Elisa Genuardi; Daniela Drandi; Daniela Barbero; Elisa Bernocco; Mario Boccadoro; Marco Ladetto
Journal:  Ther Adv Hematol       Date:  2013-06

3.  Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease.

Authors:  Esther Domingo; Cristina Moreno; Alfonso Sánchez-Ibarrola; Carlos Panizo; José Antonio Páramo; Juana Merino
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

Review 4.  Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.

Authors:  Jonathan J Hogan; Brendan M Weiss
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-14       Impact factor: 8.237

5.  Profiling human antibody responses by integrated single-cell analysis.

Authors:  Adebola O Ogunniyi; Brittany A Thomas; Timothy J Politano; Navin Varadarajan; Elise Landais; Pascal Poignard; Bruce D Walker; Douglas S Kwon; J Christopher Love
Journal:  Vaccine       Date:  2014-03-03       Impact factor: 3.641

6.  An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.

Authors:  Shoko Nakayama; Taiji Yokote; Yuji Hirata; Kazuki Iwaki; Toshikazu Akioka; Takuji Miyoshi; Ayami Takayama; Uta Nishiwaki; Yuki Masuda; Toshiyuki Ikemoto; Hidema Tanaka; Yasuichiro Nishimura; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Diagn Pathol       Date:  2012-09-28       Impact factor: 2.644

7.  Correlation between CD117+ myeloma plasma cells and hematopoietic progenitor cells in different categories of patients.

Authors:  Fanny Pojero; Alessandra Casuccio; Francesco Di Bassiano; Francesco Gervasi; Giuseppina Colonna Romano; Calogero Caruso
Journal:  Immun Ageing       Date:  2015-06-04       Impact factor: 6.400

8.  oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.

Authors:  Manabu Fujisawa; Keisuke Seike; Kouta Fukumoto; Yasuhito Suehara; Masafumi Fukaya; Hiroki Sugihara; Masami Takeuchi; Kosei Matsue
Journal:  Cancer Sci       Date:  2014-10-09       Impact factor: 6.716

9.  A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma.

Authors:  N Robillard; M C Béné; P Moreau; S Wuillème
Journal:  Blood Cancer J       Date:  2013-08-16       Impact factor: 11.037

Review 10.  Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sarah M Tete; Marc Bijl; Surinder S Sahota; Nicolaas A Bos
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.